[Problems in the use of intravenously administered immunoglobulin].
Martin
T D
TD
D006801:Humans; D007154:Immune System Diseases / Q000628:therapy; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects; D012307:Risk Factors; D012449:Safety
D016756:Immunoglobulins, Intravenous